Team
We have over a decade of experience in founding, building, scaling, and investing in deep tech companies. Our team has helped guide our founders through technical risk, market risk, product risk, regulatory risk, scientific risk, and geopolitical risk to help them build generational companies.
Joe founded Undeterred Capital in late 2020 to invest in early stage entrepreneurs fighting to bring scientific and technological innovations to the market.
Before starting Undeterred, Joe was an entrepreneur, co-founding and serving as COO of Multiply Labs, a pharma robotics company that was spun out of MIT in 2016. Multiply raised capital from Y Combinator, Lux Capital, Josh Buckley, and Casdin Capital to create robotic systems for cell and gene therapy manufacturing. After Multiply, he was a venture partner at MarsBio, an early stage biotech venture firm.
Joe is also the co-founder of the C19 Coalition, a non-profit focused on COVID-19 response whose partners helped manufacture and deliver over 1 billion PPE items, and have facilitated donations of over 5 million PPE items to frontline workers and public schools.
Several times a year, Joe lectures on deep tech commercialization, including at Duke University, MIT, Caltech, USC, and UCLA. His lectures include “Founding & Funding Disruptive Companies”, “The White Space Beyond: Creating New Markets in SynBio & Deep Tech”, and “Responding to Uncertainty in Food & Agriculture”, among others.
Joe lives in Los Angeles with his wife Lisa, their daughter Gigi, and their dog Henry.
Emily is an Associate and the Head of Research at Undeterred Capital. Her primary focus is on understanding emerging trends in deep tech and biotech and productizing this understanding through extensive industry analysis.
Additionally, Emily is an Associate, working with the investment team to diligence potential investments and support existing portfolio companies.
Emily holds a PhD in Biomechanics from UC-Berkeley with additional specializations in cell biology and material science. Prior to joining Undeterred, Emily was a Fellow at MPM Bioimpact in Boston.
Kent is a part-time researcher at Undeterred Capital, focusing on fields ranging from AI for biology to robotics to quantum computing, among others.
He has a decade of experience in research and go-to-market strategy roles, including at the Long Term Stock Exchange (LTSE).
Paul is the CFO of Undeterred Capital, serving in a part-time role. He’s responsible for operations, legal, audit, tax, annual reporting, and compliance at the firm.
Paul has over 20 years of experience as CFO at several biotech venture firms, most notably at BioStar Ventures where he has served since 2006 as CFO for the $200M firm. Previously Paul was CFO at Windward Ventures, an $85M venture firm focused on early stage investments in southern California.
Paul has also served as interim CFO for a number of portfolio companies at these funds, including Network Harmoni, which was sold to Micromuse, and Mohomine, which was sold to Kofax.
Paul was previously CEO and Chairman at VSI Enterprises where he was hired by the board of directors to implement turnaround strategies for the public company (NASDAQ "VSIN").
He has an MBA from Loyola University of Chicago and a BA in Economics from Ithaca College in New York.
Sign up for our newsletter and stay up to date with new events, webinars and opportunities from the Undeterred community.
